What is it about?
This study investigates the antidiabetic potential of Cassia bakeriana bark extracts and fractions. We evaluate their ability to inhibit α-amylase and α-glucosidase enzymes and advanced glycation end-products (AGEs).
Featured Image
Why is it important?
The EE, EAF, and n-butanol fraction (BF) exhibited strong anti-glycation capacities. Furthermore, the EE, EAF, BF, and dichloromethane fractions showed promising antioxidant activity using the DPPH and ORAC methodologies.
Perspectives
This study provides the first assessment of the antidiabetic potential of C. bakeriana bark and a comprehensive analysis of the chemical composition of its active extracts and fractions, offering hope for future treatments.
Dr. FRANCISCO JOSÉ TÔRRES DE AQUINO
Universidade Federal de Uberlandia
Read the Original
This page is a summary of: Phytochemical Profiling by HPLC‐ESI‐MS/MS and In Vitro Investigation of the Antidiabetic Activity of Cassia bakeriana Bark Extract and Fractions, Journal of Mass Spectrometry, November 2024, Wiley,
DOI: 10.1002/jms.5099.
You can read the full text:
Contributors
The following have contributed to this page
